Outcome measures and treatment effectiveness in late onset myasthenia gravis

BACKGROUND: Recently different subtypes of myasthenia gravis (MG) have been described. They differ for clinical features and pathogenesis but the prognosis and response to treatment is less clear. The aim of the study was to evaluate outcome and treatment effectiveness including side effects in late...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasqualin, Francesca, Guidoni, Silvia V., Ermani, Mario, Pegoraro, Elena, Bonifati, Domenico M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650071/
https://www.ncbi.nlm.nih.gov/pubmed/33324944
http://dx.doi.org/10.1186/s42466-020-00091-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650071/
https://www.ncbi.nlm.nih.gov/pubmed/33324944
http://dx.doi.org/10.1186/s42466-020-00091-z

Ejemplares similares